文献速递神经CTMRPET

基于[18F]FDG PET与多模态MRI的临床影像组学整合模型预测IDH突变型低级别胶质瘤ATRX突变状态

Multicenter clinical radiomics-integrated model based on [18F]FDG PET and multi-modal MRI predict ATRX mutation status in IDH-mutant lower-grade gliomas.
PubMed 文献 · Eur Radiol · 2022-08-19

最优多模态模型([18F]FDG PET+ADC+CE-T1WI)训练组和测试组AUC分别为0.971和0.962,整合KPS、SFSD和ATGR三个临床参数后AUC提升至0.987和0.975。

要点

  • IDH突变型低级别胶质瘤中,[18F]FDG PET+ADC+CE-T1WI多模态影像组学模型对ATRX突变状态预测效能高(测试组AUC 0.962)。
  • 整合KPS、SFSD、ATGR三个临床参数可进一步提升预测效能(测试组AUC 0.975)。
  • 该模型融合结构、功能与代谢信息,有望无创预测ATRX突变状态。
英文原文(摘要)· 点击展开

OBJECTIVES: To develop a clinical radiomics-integrated model based on 18 F-fluorodeoxyglucose positron emission tomography ([18F]FDG PET) and multi-modal MRI for predicting alpha thalassemia/mental retardation X-linked (ATRX) mutation status of IDH-mutant lower-grade gliomas (LGGs).

METHODS: One hundred and two patients (47 ATRX mutant-type, 55 ATRX wild-type) diagnosed with IDH-mutant LGGs (CNS WHO grades 1 and 2) were retrospectively enrolled. A total of 5540 radiomics features were extracted from structural MR (sMR) images (contrast-enhanced T1-weighted imaging, CE-T1WI; T2-weighted imaging, and T2WI), functional MR (fMR) images (apparent diffusion coefficient, ADC; cerebral blood volume, CBV), and metabolic PET images ([18F]FDG PET). The random forest algorithm was used to establish a clinical radiomics-integrated model, integrating the optimal multi-modal radiomics model with three clinical parameters. The predictive effectiveness of the models was evaluated by receiver operating characteristic (ROC) and decision curve analysis (DCA).

RESULTS: The optimal multi-modal model incorporated sMR (CE-T1WI), fMR (ADC), and metabolic ([18F]FDG) images ([18F]FDG PET+ADC+ CE-T1WI) with the area under curves (AUCs) in the training and test groups of 0.971 and 0.962, respectively. The clinical radiomics-integrated model, incorporating [18F]FDG PET+ADC+CE-T1WI, three clinical parameters (KPS, SFSD, and ATGR), showed the best predictive effectiveness in the training and test groups (0.987 and 0.975, respectively).

CONCLUSIONS: The clinical radiomics-integrated model with metabolic, structural, and functional information based on [18F]FDG PET and multi-modal MRI achieved promising performance for predicting the ATRX mutation status of IDH-mutant LGGs.

KEY POINTS: • The clinical radiomics-integrated model based on [18F]FDG PET and multi-modal MRI achieved promising performance for predicting ATRX mutation status in LGGs. • The study investigated the value of multicenter clinical radiomics-integrated model based on [18F]FDG PET and multi-modal MRI in LGGs regarding ATRX mutation status prediction. • The integrated model provided structural, functional, and metabolic information simultaneously and demonstrated with satisfactory calibration and discrimination in the training and test groups (0.987 and 0.975, respectively).

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Zhang, Pan, Liu, et al. Multicenter clinical radiomics-integrated model based on [18F]FDG PET and multi-modal MRI predict ATRX mutation status in IDH-mutant lower-grade gliomas. Eur Radiol. 2022. PMID: 35984514. doi:10.1007/s00330-022-09043-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。